{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:28:22Z","timestamp":1790288902569,"version":"4.1.0"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.aids.0000192090.61753.d4","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T08:01:56Z","timestamp":1130313716000},"page":"S199-S207","source":"Crossref","is-referenced-by-count":57,"title":["HIV\/hepatitis C virus co-infection in drug users: risk behavior and prevention"],"prefix":"10.1097","volume":"19","author":[{"given":"Holly","family":"Hagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3109\/10826089809062214","article-title":"Hepatitis C virus transmission dynamics in injection drug users","volume":"33","author":"Hagan","year":"1998","journal-title":"Subst Use Misuse"},{"key":"R2-29-20210130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S0950268802007902","article-title":"Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature","volume":"129","author":"Roy","year":"2002","journal-title":"Epidemiol Infect"},{"issue":"Suppl. 3","key":"R3-29-20210130","first-page":"59","article-title":"HIV prevention among injection drug users: the need for integrated models","volume":"80","author":"Metzger","year":"2003","journal-title":"J Urban Health"},{"issue":"Suppl. 1","key":"R4-29-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00042560-200207011-00008","article-title":"A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States","volume":"30","author":"Semaan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-29-20210130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.38286.841227.7C","article-title":"Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study","volume":"330","author":"Judd","year":"2005","journal-title":"BMJ"},{"key":"R6-29-20210130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/aje\/kwf222","article-title":"Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City","volume":"157","author":"Des Jarlais","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R7-29-20210130","first-page":"1","article-title":"Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China","volume":"33","author":"Garten","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R8-29-20210130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jech.57.4.310","article-title":"Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin","volume":"57","author":"Smyth","year":"2003","journal-title":"J Epidemiol Commun Health"},{"key":"R9-29-20210130","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/345554","article-title":"Hepatitis C virus seroconversion among young injection drug users: relationships and risks","volume":"186","author":"Hahn","year":"2002","journal-title":"J Infect Dis"},{"key":"R10-29-20210130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/jhep.2002.35065","article-title":"Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users","volume":"36","author":"Miller","year":"2002","journal-title":"Hepatology"},{"key":"R11-29-20210130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2105\/AJPH.92.3.385","article-title":"Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities","volume":"92","author":"Murrill","year":"2002","journal-title":"Am J Public Health"},{"key":"R12-29-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":"Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment","volume":"155","author":"Thorpe","year":"2002","journal-title":"Am J Epidemiol"},{"key":"R13-29-20210130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"Am J Public Health"},{"key":"R14-29-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5694\/j.1326-5377.2000.tb139199.x","article-title":"Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995\u20131997. Collaboration of Australian NSPs","volume":"172","author":"MacDonald","year":"2000","journal-title":"Med J Aust"},{"key":"R15-29-20210130","first-page":"121","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey","volume":"3","author":"Weild","year":"2000","journal-title":"Commun Dis Public Health"},{"key":"R16-29-20210130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bmj.317.7156.433","article-title":"Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study","volume":"317","author":"van Beek","year":"1998","journal-title":"BMJ"},{"key":"R17-29-20210130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5694\/j.1326-5377.1997.tb138757.x","article-title":"Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990\u20131995","volume":"167","author":"Crofts","year":"1997","journal-title":"Med J Aust"},{"key":"R19-29-20210130","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002030-199204000-00013","article-title":"Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme","volume":"6","author":"Chamot","year":"1992","journal-title":"AIDS"},{"key":"R20-29-20210130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/162.4.823","article-title":"Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam","volume":"162","author":"van den Hoek","year":"1990","journal-title":"J Infect Dis"},{"key":"R21-29-20210130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5694\/j.1326-5377.1990.tb136900.x","article-title":"Hepatitis C virus in intravenous drug users","volume":"153","author":"Bell","year":"1990","journal-title":"Med J Aust"},{"key":"R22-29-20210130","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0264-410X(98)00415-0","article-title":"Strategies to prevent and control hepatitis B and C virus infections: A global perspective","volume":"17","author":"Mast","year":"1999","journal-title":"Vaccine"},{"key":"R23-29-20210130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","article-title":"Survival analysis of time to HCV seroconversion in a cohort of Seattle IDUs","volume":"15","author":"Hagan","year":"2004","journal-title":"Epidemiology"},{"key":"R24-29-20210130","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/oxfordjournals.aje.a116021","article-title":"New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1","volume":"134","author":"Anthony","year":"1991","journal-title":"Am J Epidemiol"},{"key":"R25-29-20210130","first-page":"39","article-title":"Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City","volume":"1","author":"Marmor","year":"1987","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"R26-29-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R27-29-20210130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00002030-199603000-00010","article-title":"Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin","volume":"10","author":"Stark","year":"1996","journal-title":"AIDS"},{"key":"R28-29-20210130","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/00002030-199312000-00017","article-title":"Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users","volume":"7","author":"Jose","year":"1993","journal-title":"AIDS"},{"key":"R30-29-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1081\/JA-200030495","article-title":"Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chcago, Illinois, 1994\u20131996","volume":"40","author":"Huo","year":"2005","journal-title":"Subst Use Misuse"},{"key":"R31-29-20210130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00002030-200304110-00017","article-title":"The relevance of attributable risk measures to HIV prevention planning","volume":"17","author":"Hagan","year":"2003","journal-title":"AIDS"},{"key":"R32-29-20210130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/02791072.2003.10400492","article-title":"A potential hidden source of hepatitis C infection among noninjecting drug users","volume":"35","author":"McMahon","year":"2004","journal-title":"J Psychoactive Drugs"},{"key":"R34-29-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jurban\/jth083","article-title":"Updating the infection risk reduction hierarchy: Preventing transition into injection","volume":"81","author":"Vlahov","year":"2004","journal-title":"J Urban Health"},{"key":"R35-29-20210130","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJM199606273342602","article-title":"Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection","volume":"334","author":"Conry-Cantilena","year":"1996","journal-title":"N Engl J Med"},{"key":"R36-29-20210130","first-page":"11","article-title":"Prevalence of and risk factors for hepatitis C in blood donors","volume":"67","author":"Ladron-de Guevara","year":"2002","journal-title":"Rev Gastroenterol Mex"},{"key":"R37-29-20210130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/hep.510310329","article-title":"Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)","volume":"31","author":"Murphy","year":"2000","journal-title":"Hepatology"},{"key":"R38-29-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jmv.10407","article-title":"Hepatitis C virus infection among noninjecting drug users in New York City","volume":"70","author":"Koblin","year":"2003","journal-title":"J Med Virol"},{"key":"R39-29-20210130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1086\/375566","article-title":"Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy","volume":"37","author":"Quaglio","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R40-29-20210130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00042560-200208010-00011","article-title":"Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users","volume":"30","author":"Gyarmathy","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R41-29-20210130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1525-1497.2002.10415.x","article-title":"Risk factors for hepatitis C virus infection among homeless adults","volume":"17","author":"Nyamathi","year":"2002","journal-title":"J Gen Intern Med"},{"key":"R42-29-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1081\/JA-100102640","article-title":"Hepatitis C among noninjecting drug users: a report","volume":"36","author":"Tortu","year":"2001","journal-title":"Subst Use Misuse"},{"key":"R43-29-20210130","first-page":"145","article-title":"Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh","volume":"18","author":"Shirin","year":"2000","journal-title":"J Health, Popul Nutr"},{"key":"R44-29-20210130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007435-199811000-00006","article-title":"Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission","volume":"25","author":"Hershow","year":"1998","journal-title":"Sex Transm Dis"},{"key":"R45-29-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S0950268897007784","article-title":"Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts","volume":"119","author":"Baozhang","year":"1997","journal-title":"Epidemiol Infect"},{"key":"R46-29-20210130","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/archinte.1993.00410170111011","article-title":"Prevalence of hepatitis C in a chemically dependent population","volume":"153","author":"Fingerhood","year":"1993","journal-title":"Arch Intern Med"},{"key":"R47-29-20210130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00146260","article-title":"A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam","volume":"9","author":"van Ameijden","year":"1993","journal-title":"Eur J Epidemiol"},{"key":"R48-29-20210130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-0711-3-6","article-title":"Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user.","volume":"3","author":"McMahon","year":"2004","journal-title":"Ann Clin Microbiol Antimicrob (serial online) May"},{"key":"R49-29-20210130","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.OLQ.0000091152.31366.E6","article-title":"Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997\u20132000","volume":"30","author":"Hammer","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R50-29-20210130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2796.1994.tb00838.x","article-title":"Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings","volume":"236","author":"Soto","year":"1994","journal-title":"J Intern Med"},{"key":"R51-29-20210130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1293.2004.00207.x","article-title":"HIV and hepatitis C coinfection within the CAESAR study","volume":"5","author":"Amin","year":"2004","journal-title":"HIV Med"},{"key":"R52-29-20210130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00126334-200307010-00011","article-title":"The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy","volume":"33","author":"Klein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R53-29-20210130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1468-1293.2003.00152.x","article-title":"HIV\/HBV and HIV\/HCV coinfection, and outcomes following highly active antiretroviral therapy","volume":"4","author":"Lincoln","year":"2003","journal-title":"HIV Med"},{"key":"R54-29-20210130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1086\/374649","article-title":"Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women","volume":"287","author":"Stover","year":"2003","journal-title":"J Infect Dis"},{"key":"R55-29-20210130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"R56-29-20210130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2893.1999.t01-1-6120135.x","article-title":"Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study","volume":"6","author":"Fainboim","year":"1999","journal-title":"J Viral Hepat"},{"key":"R57-29-20210130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jmv.1890460412","article-title":"Detection of HCV RNA in serum and seminal fluid from HIV-1 co-infected intravenous drug addicts","volume":"46","author":"Fiore","year":"1995","journal-title":"J Med Virol"},{"key":"R58-29-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jmv.1890420106","article-title":"Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort)","volume":"42","author":"Quaranta","year":"1994","journal-title":"J Med Virol"},{"key":"R59-29-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/clinids\/17.1.117","article-title":"Hepatitis C virus infection in patients infected with the human immunodeficiency virus","volume":"17","author":"Quan","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R60-29-20210130","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1086\/377585","article-title":"Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II","volume":"188","author":"Hisada","year":"2003","journal-title":"J Infect Dis"},{"key":"R61-29-20210130","first-page":"2071","article-title":"Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York city metropolitan area","volume":"97","author":"Brau","year":"2002","journal-title":"J Gastroenterol"},{"key":"R62-29-20210130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/jhep.2001.25759","article-title":"Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco","volume":"34","author":"Hahn","year":"2001","journal-title":"Hepatology"},{"key":"R63-29-20210130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199502163320707","article-title":"Management of occupational exposures to blood-borne viruses","volume":"332","author":"Gerberding","year":"1995","journal-title":"N Engl J Med"},{"key":"R64-29-20210130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00535-003-1156-1","article-title":"Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel","volume":"38","author":"Chung","year":"2003","journal-title":"J Gastroenterol"},{"key":"R65-29-20210130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1023\/A:1014560431726","article-title":"Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users","volume":"17","author":"Hernandez-Aguado","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"R66-29-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365549609027145","article-title":"Incidence rate and risk factors for HCV seroconversions among injecting drug users in an area with low HIV seroprevalence","volume":"28","author":"Rezza","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"R67-29-20210130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1360-0443.1997.tb02979.x","article-title":"Methadone maintenance and hepatitis C virus infection among injecting drug users","volume":"92","author":"Crofts","year":"1997","journal-title":"Addiction"},{"key":"R68-29-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"Hagan","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R69-29-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02386744","article-title":"Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area","volume":"77","author":"Thiede","year":"2000","journal-title":"J Urban Health"},{"key":"R70-29-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0740-5472(01)00213-6","article-title":"A nationwide survey of hepatitis C services provided by drug treatment programs","volume":"22","author":"Strauss","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"R71-29-20210130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s100960000377","article-title":"National survey of hepatitis testing and vaccination services provided by drug services in England and Wales","volume":"19","author":"Winstock","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R72-29-20210130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02386747","article-title":"Changes in injection risk behavior associated with participation in the Seattle needle-exchange program","volume":"77","author":"Hagan","year":"2000","journal-title":"J Urban Health"},{"issue":"Suppl. 1","key":"R73-29-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00042560-199802001-00008","article-title":"Syringe use and reuse: Effects of syringe exchange programs in four cities","volume":"18","author":"Heimer","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R74-29-20210130","first-page":"121","article-title":"Syringe exchange use and HIV risk reduction over time","volume":"12","author":"Paone","year":"1998","journal-title":"AIDS"},{"key":"R75-29-20210130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jama.1994.03510260047027","article-title":"Syringe and needle exchange as HIV\/AIDS prevention for injection drug users","volume":"271","author":"Watters","year":"1994","journal-title":"JAMA"},{"key":"R76-29-20210130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/01.qai.0000120802.43677.ea","article-title":"HIV risk practices among needle exchange users and nonusers in Chicago","volume":"37","author":"Ouellet","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R77-29-20210130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(96)02536-6","article-title":"HIV incidence among injecting drug users in New York City syringe-exchange programmes","volume":"348","author":"Des Jarlais","year":"1996","journal-title":"Lancet"},{"key":"R78-29-20210130","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(96)11380-5","article-title":"Effectiveness of needle-exchange programmes for prevention of HIV infection","volume":"349","author":"Hurley","year":"1997","journal-title":"Lancet"},{"key":"R79-29-20210130","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","article-title":"Needle exchange is not enough: lessons from the Vancouver injecting drug use study","volume":"11","author":"Strathdee","year":"1997","journal-title":"AIDS"},{"key":"R80-29-20210130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/oxfordjournals.aje.a009240","article-title":"High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study","volume":"146","author":"Bruneau","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R81-29-20210130","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2105\/AJPH.85.11.1531","article-title":"Reduced risk of hepatitis B and hepatitis C among injecting drug users participating in the Tacoma Syringe-Exchange Program","volume":"85","author":"Hagan","year":"1995","journal-title":"Am J Public Health"},{"key":"R82-29-20210130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/oxfordjournals.aje.a009794","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"Hagan","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R83-29-20210130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02386747","article-title":"Changes in injection risk behavior associated with participation in the Seattle needle-exchange program","volume":"77","author":"Hagan","year":"2000","journal-title":"J Urban Health"},{"key":"R84-29-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365540050165875","article-title":"Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe\/needle exchange program","volume":"32","author":"Mansson","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"R85-29-20210130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1360-0443.2002.00128.x","article-title":"Over a decade of syringe exchange: results from 1997 UK survey","volume":"97","author":"Parsons","year":"2002","journal-title":"Addiction"},{"key":"R86-29-20210130","first-page":"339","article-title":"Harm reduction: Australia as a case study","volume":"72","author":"Wodak","year":"1995","journal-title":"Bull NY Acad Med"},{"key":"R87-29-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/00365540152029936","article-title":"Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle\/syringe exchange","volume":"33","author":"Goldberg","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"R88-29-20210130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2105\/AJPH.91.1.38","article-title":"Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?","volume":"91","author":"Hope","year":"2001","journal-title":"Am J Public Health"},{"key":"R89-29-20210130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1360-0443.1997.tb02979.x","article-title":"Methadone maintenance and hepatitis C virus infection among injecting drug users","volume":"92","author":"Crofts","year":"1997","journal-title":"Addiction"},{"key":"R90-29-20210130","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"Can Med Assoc J"},{"issue":"Suppl 3","key":"R92-29-20210130","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","article-title":"Reductions in hepatitis C virus and HIV infections among drug users in New York City, 1990-2001.","volume":"19","author":"Des Jarlais","year":"2005","journal-title":"AIDS"},{"key":"R93-29-20210130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1293.2004.00207.x","article-title":"HIV and hepatitis C coinfection within the CAESAR study","volume":"5","author":"Amin","year":"2004","journal-title":"HIV Med"},{"key":"R94-29-20210130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archinte.161.10.1281","article-title":"Sex differences in risk factors for HIV seroconversions among injection drug users: a 10-year perspective","volume":"161","author":"Strathdee","year":"2001","journal-title":"Arch Intern Med"},{"key":"R95-29-20210130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(00)04562-1","article-title":"Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis","volume":"357","author":"Kral","year":"2001","journal-title":"Lancet"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.aids.0000192090.61753.d4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:45:11Z","timestamp":1620935111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200510003-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":91,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000192090.61753.d4","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}